Abiopharma

🔍 Sbrocco Gregory (Executive)

Company: WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP (WAB)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 3,727 shares of Common Stock - Direct (Direct)
  Date: 2026-05-05 | Code: X | equity_swap_involved: 0 | shares_owned_after: 25,722.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,727 shares of Common Stock - Direct at $263.44 per share (Direct)
  Date: 2026-05-05 | Code: J | equity_swap_involved: 0 | shares_owned_after: 21,995.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,727 shares of Phantom Stock (Derivative)
  Date: 2026-05-05 | Code: X | equity_swap_involved: 0 | shares_owned_after: 4,555.00 | transaction_form_type: 4 | Footnotes: F2, F1, F2, F2

Footnotes:

• F1: Each share of phantom stock is the economic equivalent of one share of Westinghouse Air Brake Technologies Corporation's common stock. The reporting person settled his shares of phantom stock for cash at the price of $263.44 per share in connection with a fund transfer within the Westinghouse Air Brake Technologies Corporation Deferred Compensation Plan for Executive Officers and Directors.
• F2: The phantom stock was payable according to the election of payment designation filed by the reporting person subject to the Westinghouse Air Brake Technologies Corporation Deferred Compensation Plan for Executive Officers and Directors and could be transferred into an alternative investment fund at any time.